The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $12.83

Today's change-0.21 -1.61%
Updated August 17 12:34 PM EDT. Delayed by at least 15 minutes.
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $12.83

Today's change-0.21 -1.61%
Updated August 17 12:34 PM EDT. Delayed by at least 15 minutes.

Sharp drop following new 52-week high

China Cord Blood Corp is sharply lower today, dropping (U.S.)$0.21 or 1.61% to (U.S.)$12.83 after setting a new 52-week high. Over the last five days, shares have gained 6.65% and are currently 2.95% off of the 52-week high. Shares have outperformed the S&P 500 by 143.91% during the last year.

Key company metrics

  • Open(U.S.) $13.03
  • Previous close(U.S.) $13.04
  • High(U.S.) $13.05
  • Low(U.S.) $12.59
  • Bid / Ask(U.S.) $12.81 / (U.S.) $12.84
  • YTD % change+109.64%
  • Volume123,320
  • Average volume (10-day)430,655
  • Average volume (1-month)494,490
  • Average volume (3-month)503,342
  • 52-week range(U.S.) $4.27 to (U.S.) $13.22
  • Beta0.93
  • Trailing P/E53.77×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.24
Updated August 17 12:34 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2017Q3/2017Q2/2017Q1/2017
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue202201184173
Total other revenue--------
Total revenue202201184173
Gross profit161176145136
Total cost of revenue41253937
Total operating expense146102129121
Selling / general / administrative102988881
Research & development3322
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)030--
Other operating expenses, total0-26----
Operating income56995552
Interest income (expense), net non-operating-30-31-30-29
Gain (loss) on sale of assets--------
Other--------
Income before tax35733028
Income after tax39561716
Income tax, total-4171312
Net income38561716
Total adjustments to net income-10------
Net income before extra. items38561716
Minority interest-10-10
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items28561716
Inc. avail. to common incl. extra. items28561716
Diluted net income28561716
Dilution adjustment--------
Diluted weighted average shares73737373
Diluted EPS excluding extraordinary itemsvalue per share0.380.770.230.22
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.380.790.230.22